drugset / Trial / NCT00693602
Compassionate Use of Erwinase For Pediatric Patients With Acute Lymphoblastic Leukemia Or Non Hodgkins Lymphoma
Phase 1
Completed
87 enrolled
St. Jude Children's Research Hospital
Jazz Pharmaceuticals · collabParexel · collab
NaSingle-groupOpen-labelSupportive care
Summary
This is a compassionate use protocol for patients with acute lymphoblastic leukemia (ALL) who have developed hypersensitivity or intolerance to E. coli L-asparaginase and/or PEG-L-asparaginase.
Timeline
- Start
- 2006-06
- Primary completion
- 2011-12
- Completion
- 2011-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Asparaginase Erwinia chrysanthemi | Protein / enzyme biologic | — | — |